UBS Group Issues Positive Forecast for Nutrien (NYSE:NTR) Stock Price

Nutrien (NYSE:NTRGet Free Report) had its price target raised by investment analysts at UBS Group from $52.00 to $56.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. UBS Group’s target price would indicate a potential upside of 0.74% from the stock’s current price.

A number of other research firms have also recently commented on NTR. Berenberg Bank boosted their price target on shares of Nutrien from $54.00 to $59.00 and gave the stock a “buy” rating in a research note on Tuesday, April 15th. Oppenheimer reduced their target price on Nutrien from $60.00 to $58.00 and set an “outperform” rating on the stock in a research note on Tuesday, April 22nd. JPMorgan Chase & Co. raised Nutrien from an “underweight” rating to a “neutral” rating and lifted their price target for the stock from $40.00 to $50.00 in a research note on Monday, January 13th. Piper Sandler raised their price objective on Nutrien from $58.00 to $63.00 and gave the company an “overweight” rating in a report on Monday, January 27th. Finally, CIBC upped their target price on Nutrien from $64.00 to $66.00 and gave the stock an “outperformer” rating in a research note on Tuesday, February 25th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $59.93.

Read Our Latest Analysis on NTR

Nutrien Stock Up 1.5 %

NTR stock opened at $55.59 on Thursday. Nutrien has a twelve month low of $43.70 and a twelve month high of $60.87. The firm has a market capitalization of $27.14 billion, a PE ratio of 40.58, a PEG ratio of 1.19 and a beta of 0.79. The company has a quick ratio of 0.82, a current ratio of 1.27 and a debt-to-equity ratio of 0.38. The stock has a 50-day simple moving average of $51.97 and a two-hundred day simple moving average of $49.95.

Nutrien (NYSE:NTRGet Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.35 by ($0.24). Nutrien had a return on equity of 6.81% and a net margin of 2.62%. The firm had revenue of $4.67 billion during the quarter, compared to the consensus estimate of $5.16 billion. During the same period in the previous year, the company posted $0.46 EPS. The company’s revenue for the quarter was down 5.4% compared to the same quarter last year. On average, equities analysts predict that Nutrien will post 3.72 EPS for the current fiscal year.

Institutional Investors Weigh In On Nutrien

A number of large investors have recently made changes to their positions in NTR. Vanguard Group Inc. lifted its stake in Nutrien by 7.1% in the first quarter. Vanguard Group Inc. now owns 21,191,003 shares of the company’s stock worth $1,051,709,000 after acquiring an additional 1,412,503 shares during the period. Dodge & Cox lifted its position in shares of Nutrien by 0.3% in the 4th quarter. Dodge & Cox now owns 12,523,259 shares of the company’s stock worth $560,416,000 after purchasing an additional 40,800 shares during the period. Silchester International Investors LLP boosted its stake in shares of Nutrien by 9.5% during the 4th quarter. Silchester International Investors LLP now owns 11,693,137 shares of the company’s stock valued at $523,268,000 after purchasing an additional 1,009,895 shares in the last quarter. First Eagle Investment Management LLC increased its position in shares of Nutrien by 0.8% during the fourth quarter. First Eagle Investment Management LLC now owns 9,529,311 shares of the company’s stock valued at $426,436,000 after buying an additional 77,174 shares during the period. Finally, Mackenzie Financial Corp raised its stake in Nutrien by 0.7% in the first quarter. Mackenzie Financial Corp now owns 7,855,609 shares of the company’s stock worth $389,860,000 after buying an additional 54,918 shares in the last quarter. 63.10% of the stock is currently owned by institutional investors.

About Nutrien

(Get Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Featured Articles

Analyst Recommendations for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.